HL
Harding Loevner Portfolio holdings
AUM
$14.9B
This Quarter Return
-18.07%
1 Year Return
+22.61%
3 Year Return
+105.58%
5 Year Return
+159.12%
10 Year Return
+355.06%
AUM
$16.2B
AUM Growth
+$16.2B
(-11%)
Cap. Flow
-$600M
Cap. Flow
% of AUM
-3.7%
Top 10 Holdings %
Top 10 Hldgs %
39.27%
Holding
158
New
5
Increased
13
Reduced
69
Closed
5
Top Buys
| 1 |
Woodside Energy
WDS
|
$117M |
| 2 |
Manulife Financial
MFC
|
$70M |
| 3 |
Fomento Económico Mexicano
FMX
|
$54.8M |
| 4 |
iShares MSCI ACWI ex US ETF
ACWX
|
$44.9M |
| 5 |
HDFC Bank
HDB
|
$42.7M |
Top Sells
| 1 |
Meta Platforms (Facebook)
META
|
$283M |
| 2 |
Check Point Software Technologies
CHKP
|
$243M |
| 3 |
BHP
BHP
|
$128M |
| 4 |
Ambev
ABEV
|
$85.3M |
| 5 |
CME Group
CME
|
$64.2M |
Sector Composition
| 1 | Technology | 21.76% |
| 2 | Healthcare | 17.83% |
| 3 | Financials | 17.34% |
| 4 | Industrials | 9.33% |
| 5 | Materials | 6.89% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
Core Laboratories
CLB
$553M
| $2.29M | 0.01% |
115,679
+3,691
| +3% | +$73.1K |
|
77
Vanguard FTSE Developed Markets ETF
VEA
$169B
| $2.04M | 0.01% |
50,078
+21,610
| +76% | +$882K |
|
|
78
Check Point Software Technologies
CHKP
$20.6B
| $2M | 0.01% |
16,383
-1,999,387
| -99% | -$243M |
|
79
Ecopetrol
EC
$18.6B
| $1.73M | 0.01% |
159,637
-308,102
| -66% | -$3.35M |
|
80
iShares MSCI EAFE ETF
EFA
$65.4B
| $644K | ﹤0.01% |
10,301
+4,957
| +93% | +$310K |
|
81
Vanguard Total World Stock ETF
VT
$51.4B
| $424K | ﹤0.01% |
4,970
-1,520
| -23% | -$130K |
|
82
iShares Global 100 ETF
IOO
$7.02B
| $224K | ﹤0.01% |
+3,489
| New | +$224K |
|
|
NBIS
83
Nebius Group N.V. Class A Ordinary Shares
NBIS
$15.7B
| $217K | ﹤0.01% |
8,595,712
-308,325
| -3% | -$7.78K |
|
84
BioNTech
BNTX
$24.1B
| $179K | ﹤0.01% |
+1,202
| New | +$179K |
|
85
Banco Santander
SAN
$140B
| $138K | ﹤0.01% |
49,212
| – | – |
|
86
NetEase
NTES
$85.4B
| $133K | ﹤0.01% |
1,424
-82,698
| -98% | -$7.72M |
|
87
AbbVie
ABBV
$374B
| $98K | ﹤0.01% |
637
| – | – |
|
88
BorgWarner
BWA
$9.3B
| $85K | ﹤0.01% |
2,544
| – | – |
|
89
Bristol-Myers Squibb
BMY
$96.7B
| $84K | ﹤0.01% |
1,086
| – | – |
|
90
Neurocrine Biosciences
NBIX
$13.5B
| $79K | ﹤0.01% |
810
| – | – |
|
91
Reinsurance Group of America
RGA
$13B
| $79K | ﹤0.01% |
671
| – | – |
|
92
Gartner
IT
$18.8B
| $75K | ﹤0.01% |
311
| – | – |
|
93
Ollie's Bargain Outlet
OLLI
$7.89B
| $73K | ﹤0.01% |
1,243
| – | – |
|
94
Merck
MRK
$210B
| $67K | ﹤0.01% |
734
| – | – |
|
95
JPMorgan Chase
JPM
$824B
| $66K | ﹤0.01% |
589
| – | – |
|
96
Elanco Animal Health
ELAN
$8.62B
| $63K | ﹤0.01% |
3,234
| – | – |
|
97
HEICO
HEI
$44.4B
| $55K | ﹤0.01% |
419
| – | – |
|
98
Teradyne
TER
$19B
| $55K | ﹤0.01% |
618
| – | – |
|
99
Malibu Boats
MBUU
$611M
| $49K | ﹤0.01% |
939
| – | – |
|
100
Zoetis
ZTS
$67.6B
| $45K | ﹤0.01% |
261
| – | – |
|